Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Rutgers Names David Kimball as VP for Innovation and Research Commercialization of Office of Research and Economic Development

10/26/2017

0 Comments

 
Picture
New Brunswick, NJ — Rutgers University on October 23 announced the appointment of David Kimball, Ph.D., as vice president for innovation and research commercialization of the Office of Research and Economic Development (ORED).
 
Most recently, Dr. Kimball led translational science and research commercialization as associate vice president in ORED).
 
“I am delighted to announce David’s promotion to Vice President of Innovation and Research Commercialization,” said Christopher J. Molloy, Ph.D., R.Ph., Senior Vice President for Research and Economic Development at Rutgers University.
 
“He brings a wealth of experience to the role, and I am confident that he will continue to provide excellent leadership to the team and bring further success to Rutgers.”


​As associate vice president, Dr. Kimball successfully reorganized and rebuilt the technology transfer capabilities of Rutgers post-merger. He deployed a robust decision process to rapidly evaluate and progress faculty inventions, and established a software and copyright licensing group.
 
Dr. Kimball also accessed funding to launch the TechAdvance® gap funding program in 2017, and established relationships with external sources leading to the successful funding of Rutgers startups.
 
He continued to build the capabilities of the Rutgers Translational Science (RTS) group.  Under his leadership, the Office of Research Commercialization achieved record revenues in FY2017.
 
In his role as Vice President, Innovation and Research Commercialization, Dr. Kimball will continue to transform research at Rutgers into products, services and partnerships for the public good that generate value for the university and enhance the economic development of New Jersey.
 
His responsibilities will include the continued expansion of RTS to assist biomedical researchers in obtaining high-value grants and intellectual property. He will also advance efforts to standardize and optimize intellectual property, marketing and licensing processes, and spread the copyright and software licensing franchise across the university.
 
Dr. Kimball expects to further grow TechAdvance and startup companies, and vigorously expand outreach to external stakeholders, sources of funding and to faculty at all campuses of Rutgers University.
 
Dr. Kimball is also a research professor of medicinal chemistry in the Ernest Mario School of Pharmacy at Rutgers, and is an associate in the Cancer Pharmacology Research Program, which aims to promote more effective cancer treatments.
 
He is a scientific founder of Z53 Therapeutics, a company focused on designing novel oncology therapeutics to target tumors with mutations in the tumor suppressor gene, p53.
 
Prior to joining Rutgers in 2011, Dr. Kimball spent 30 years in the pharmaceutical and biotechnology industries in positions ranging from bench scientist to chief scientific officer, leading drug discovery and development efforts.
 
His research has covered anti-infective agents, cardiovascular disease, oncology, immunology, neuropsychiatric and neurodegenerative disease.
 
Dr. Kimball has lectured widely on drug discovery and has been associated with the Ernest Mario School of Pharmacy at Rutgers University since 1989. He holds a Ph.D. in Organic Chemistry/Chemical Biology from the State University of New York at Stony Brook.
 
 
 
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Powered by Create your own unique website with customizable templates.